Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC22H20O4 |
InChIKeyJTTAVDAEVCLLLX-UHFFFAOYSA-N |
CAS Registry24909-18-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | TH | 04 Jan 2022 |